2 Life Sciences Cos. Set Terms Amid Quiet Period For IPOs
Two venture capital-backed life sciences companies — a commercial-stage diabetes treatment maker and an orphan disease treatment developer — fine-tuned their initial public offering plans Monday as a so-far relatively quiet...To view the full article, register now.
Already a subscriber? Click here to view full article